Glenmark Pharmaceuticals Ltd has reported consolidated net profit growth of 15.52 per cent to Rs 94.07 crore for the third quarter ended December 31, 2009, over the corresponding period last year.
Cadila needs to prove of VLP technology safe before conducting clinical trials, says DCGI
An experimental vaccine against chikungunya virus infection has shown promise, according to reserachers at the National Institute of Allergy and Infectious Diseases (NIAID).
The government of India has brought into effect stricter norms for obtaining No Objection Certificates (NOCs) for pharmaceutical exporters.
Early Result Pregnancy Test can determine pregnancy up to six days
World's top drug maker Pfizer will compensate the victims of unethical clinical trial in the African state of Kano using its menigitis vaccine Trovan with not less than N26, 250, 000 (Naira, nigerian currency) per person, reports said.
India’s leading generic player Cipla Ltd has posted a net profit of Rs 2890.30 million for the quarter ended December 31, 2009 as compared to Rs 2234.40 million for the quarter ended December 31, 2008.
CK-2017357 is a fast skeletal muscle troponin activator
Banking life saving umbilical cord blood of your child will offer a potential resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.